Biograph, founded in 2017, operates advanced diagnostic clinics in San Francisco and New York City offering comprehensive early disease detection and personalized longevity medicine. The company's core service is a membership-based health evaluation completed in a single day, combining over 30 advanced diagnostics including full-body MRI, blood panels, VO2 max testing, and DEXA scans to generate more than 1,000 data points per assessment.
The diagnostic data feeds into personalized risk profiles organized across five health domains: cardiovascular disease, metabolic dysfunction, neurodegenerative disease, cancer risk, and quality-of-life indicators. Members receive expert-guided clinical recommendations tailored to their individual profiles, covering exercise, nutrition, sleep, mental health, and medication considerations. The service reflects a clinician-led approach to preventive medicine, combining deep diagnostics with actionable, personalized guidance.
Biograph was co-founded by Dr. Peter Attia, author of the New York Times bestseller Outlive. The company is backed by significant venture investment and positions itself as a leader in the preventive health and longevity clinic space.